|Whitelist of investors:||No|
|KYC of investors:||No|
|Goal of funding (Soft cap):||5 000 000 USD|
|Goal of funding (Hard cap):||550 000 000 USD|
|Tokens for sale:||230 000 000 PONX|
|Token price:||1 PONX = 0.10 USD|
|Have escrow agent:||No|
|Have working prototype:||No|
|Currencies:||BTC, ETH, XRP|
|Restricted areas:||North Korea|
Biohal's mission is to create a universally available preventive medicine platform that runs on blockchain with liquid biopsy protocol. By joining hands with PROTEO, the first liquid biopsy research partner, Biohal can detect cancer and alzheimers at early stages. With minimally invasive markers, Biohal's test accuracy remains at 99%.
ZENITH introduces the opening of the world’s first blockchain organization to help world health, Sm...
A new revolution in the medical industry begins with MEDK project. Based on blockchain technology, M...
An $872 billion dollar industry on the Blockchain, enabling access to affordable healthcare globally...
Helix3 is a platform that offers a secure way for the healthcare industry to drive patient value, en...
We are a group of enthusiasts who believe, that every person can make a difference by supporting the...
The TeamMate Network aims to integrate the health, fitness and wellness industries into a unified bl...
As a response to rapidly emerging eye health problem EyeGlob.Net will provide a mix of social and pr... Full info
Doctor Smart is an ecosystem for digital health based on unique technology. The platform uses utilit...
Functional water with unique health benefits